Skip to main content
SpringerLink
Log in

Common Psychotropic Treatments Used in Dermatology, How and When to Use

  • Chapter
  • First Online:
Book cover The Essentials of Psychodermatology

  • 327 Accesses

Abstract

In this chapter, we present general concepts linked with the prescription of psychotropic treatments in psychodermatology, emphasizing the antidepressants, the antiepileptics, the antihistamines, the benzodiazepines and the psychobiotics, with basic principles applied to the main groups of psychodermatologic disorders. The management in psychodermatology is multifaceted, also including the skin care, depending on the type of dermatosis or skin illness. Complementary treatments, particularly, psychotherapy should be considered, depending on the psychopathology and its severity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 89.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ferreira BR, Cardoso JC. Herpes and stress. In: França K, Jafferany M, editors. Stress and skin disorders: Springer, Switzerland; 2017. p. 209–25.

    Google Scholar 

  2. Kotara S, Magid M, Burrows M. Psychopharmacology in psychodermatology. In: Bewley A, Taylor RE, Reichenberg JS, Magid M, editors. Practical psychodermatology: Wiley, UK; 2014. p. 21–32.

    Google Scholar 

  3. Nadkarni S, Devinsky O. Psychotropic effects of antiepileptic drugs. Epilepsy Curr. 2005;5(5):176–81.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ferreira BR, Pio-Abreu JL, Reis JP, Figueiredo A. First psychodermatology clinic in a Portuguese Department of Dermatology. J Eur Acad Dermatol Venereol. 2019;33(3):e119–20.

    Article  CAS  PubMed  Google Scholar 

  5. Tomas-Aragones L, Consoli SM, Consoli SG, Poot F, Taube KM, Linder MD, Jemec GB, Szepietowski JC, de Korte J, Lvov AN, Gieler U. Self-inflicted lesions in dermatology: a management and therapeutic approach – a position paper from the European Society for Dermatology and Psychiatry. Acta Derm Venereol. 2017;97(29):159–72.

    Article  PubMed  Google Scholar 

  6. Singh AR, Veale D. Understanding and treating body dysmorphic disorder. Indian J Psychiatry. 2019;61(Suppl 1):S131–5.

    PubMed  PubMed Central  Google Scholar 

  7. Arnold LM, Auchenbach MB, McElroy SL. Psychogenic excoriation. Clinical features, proposed diagnostic criteria, epidemiology and approaches to treatment. CNS Drugs. 2011;15(5):351–9.

    Article  Google Scholar 

  8. Ferreira BR, Roccia MG, Cardoso JC, França K, Wollina U, Lotti T, Fioranelli M. History of Morgellons disease: the same name for different psychodermatologic diseases? Wien Med Wochenschr. 2017;167(Suppl 1):49–51.

    Article  PubMed  Google Scholar 

  9. Rodríguez Martín AM, González PM. Psychotropic drugs in dermatology. Actas Dermosifiliogr. 2015;106(6):507–9.

    Article  PubMed  Google Scholar 

  10. Shah B, Levenson JL. Use of psychotropic drugs in the dermatology patient: when to start and stop? Clin Dermatol. 2018;36(6):748–55.

    Article  PubMed  Google Scholar 

  11. Gupta MA, Pur DR, Vujcic B, Gupta AK. Use of antiepileptic mood stabilizers in dermatology. Clin Dermatol. 2018;36(6):756–64.

    Article  PubMed  Google Scholar 

  12. Gupta MA. Emotional regulation, dissociation, and the self-induced dermatoses: clinical features and implications for treatment with mood stabilizers. Clin Dermatol. 2013;31(1):110–7.

    Article  PubMed  Google Scholar 

  13. Gupta MA, Vujcic B, Pur DR, Gupta AK. Use of antipsychotic drugs in dermatology. Clin Dermatol. 2018;36(6):765–73.

    Article  PubMed  Google Scholar 

  14. Gieler U, Consoli SG, Tomás-Aragones L, Linder DM, Jemec GB, Poot F, Szepietowski JC, de Korte J, Taube KM, Lvov A, Consoli SM. Self-inflicted lesions in dermatology: terminology and classification – a position paper from the European Society for Dermatology and Psychiatry (ESDaP). Acta Derm Venereol. 2013;93(1):4–12.

    Article  PubMed  Google Scholar 

  15. Amber KT, Murrell DF, Schmidt E, Joly P, Borradori L. Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management. Clin Rev Allergy Immunol. 2018;54(1):26–51.

    Article  PubMed  Google Scholar 

  16. Ferreira BR, Reis JP, Cardoso JC. Dermatopathology and trichotillomania. In: França K, Jafferany M, editors. Trichotillomania (hair pulling disorders): clinical characteristics, psychological interventions and emotional effects: Nova Science Publishers, NY; 2017. p. 35–53.

    Google Scholar 

  17. Pio-Abreu JL. Elementos de psicopatologia explicativa. Fundação Calouste Gulbenkian, 2014.

    Google Scholar 

  18. Williams C, Garland A. A cognitive–behavioural therapy assessment model for use in everyday clinical practice. Adv Psychiatr Treat. 2002;8(3):172–9.

    Article  Google Scholar 

  19. Jafferany M, Kobusiewicz A, Ferreira BR, Garan S, Havryliuk O. Factitious disorders in children: clinical and therapeutic consideration. Dermatol Venereol. 2019;2(84):8–14.

    Article  Google Scholar 

  20. Couto JP, Moureira R. Oral N-acetylcysteine in the treatment of obsessive-compulsive disorder. A systematic review of the clinical evidence. Prog Neuro-Psychopharmacol Biol Psychiatry. 2018;86:245–54.

    Article  CAS  Google Scholar 

  21. Adil M, Amin SS, Mohtashim M. N-acetylcysteine in dermatology. Indian J Dermatol Venereol Leprol. 2018;84(6):652–9.

    Article  PubMed  Google Scholar 

  22. Reamv BV, Bunt CW, Fletcher S. A diagnostic approach to pruritus. Am Fam Physician. 2011;84(2):195–202.

    Google Scholar 

  23. Szepietowski JC, Reszke R. Psychogenic itch management. Curr Probl Dermatol. 2016;50:124–32.

    Article  PubMed  Google Scholar 

  24. Khanna R, Boozalis E, Belzberg M, Zampella JG, Kwatra SG. Mirtazapine for the treatment of chronic pruritus. Medicine (Basel). 2019;6(3). Pii: E73.

    Google Scholar 

  25. Misery L, Dutray S, Chastaing M, Schollhammer M, Consoli SG, Consoli SM. Psychogenic itch. Transl Psychiatry. 2018;8(1):52.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Lynch PJ, Edwards L. Chronic idiopathic mucocutaneous pain syndromes: vulvodynia, penodynia, and scrotodynia. In: Bewley A, Taylor RE, Reichenberg JS, Magid M, editors. Practical psychodermatology: Wiley, UK; 2014. p. 173–9.

    Google Scholar 

  27. Morr Verenzuela CS, Davis MDP, Bruce AJ, Torgerson RR. Burning mouth syndrome: results of screening tests for vitamin and mineral deficiencies, thyroid hormone, and glucose levels-experience at Mayo Clinic over a decade. Int J Dermatol. 2017;56(9):952–6.

    Article  CAS  PubMed  Google Scholar 

  28. Bruce A, Torgerson RR, Wriston CC, Gonzalez Santiago TM. Burning mouth syndrome. In: Bewley A, Taylor RE, Reichenberg JS, Magid M, editors. Practical psychodermatology: Wiley, UK; 2014. p. 180–5.

    Google Scholar 

  29. Yamazaki Y, Hata H, Kitamori S, Onodera M, Kitagawa Y. An open-label, noncomparative, dose escalation pilot study of the effect of paroxetine in treatment of burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107(1):e6–11.

    Article  PubMed  Google Scholar 

  30. Teruel A, Patel S. Burning mouth syndrome: a review of etiology, diagnosis, and management. Gen Dent. 2019;67(2):24–9.

    PubMed  Google Scholar 

  31. Ueda N, Kodama Y, Hori H, Umene W, Sugita A, Nakano H, Yoshimura R. Nakamura. Two cases of burning mouth syndrome treated with olanzapine. Psychiatry Clin Neurosci. 2008;62(3):359–61.

    Article  CAS  PubMed  Google Scholar 

  32. Nevels RM, Gontkovsky ST, Williams BE. Paroxetine-the antidepressant from hell? Probably not, but caution required. Psychopharmacol Bull. 2016;46(1):77–104.

    PubMed  PubMed Central  Google Scholar 

  33. Lepping P, Freudenmann R, Huber M. Delusional infestation. In: Bewley A, Taylor RE, Reichenberg JS, Magid M, editors. Practical psychodermatology: Wiley, UK; 2014. p. 117–26.

    Google Scholar 

  34. Wong JW, Koo JY. Psychopharmacological therapies in dermatology. Dermatol Online J. 2013;19(5):18169.

    Article  PubMed  Google Scholar 

  35. Reich A, Kwiatkowska D, Pacan P. Delusions of Parasitosis: an update. Dermatol Ther (Heidelb). 2019;9(4):631–8.

    Article  Google Scholar 

  36. Altınöz AE, Tosun Altınöz Ş, Küçükkarapınar M, Coşar B. Paliperidone: another treatment option for delusional parasitosis. Australas Psychiatry. 2014;22(6):576–8.

    Article  PubMed  Google Scholar 

  37. Phillips KA, Keshaviah A, Dougherty DD, Stout RL, Menard W, Wilhelm S. Pharmacotherapy relapse prevention in body dysmorphic disorder: a double-blind, placebo-controlled trial. Am J Psychiatry. 2016;173(9):887–95.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Dong N, Nezgovorova V, Hong K, Hollander E. Pharmacotherapy in body dysmorphic disorder: relapse prevention and novel treatments. Expert Opin Pharmacother. 2019;20(10):1211–9.

    Article  CAS  PubMed  Google Scholar 

  39. Bambury A, Sandhu K, Cryan JF, Dinan TG. Finding the needle in the haystack: systematic identification of psychobiotics. Br J Pharmacol. 2018;175(24):4430–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Sarkar A, Lehto SM, Harty S, Dinan TG, Cryan JF, Burnet PWJ. Psychobiotics and the manipulation of bacteria-gut-brain signals. Trends Neurosci. 2016;39(11):763–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Long-Smith C, O’Riordan KJ, Clarke G, Stanton C, Dinan TG, Cryan JF. Microbiota-gut-brain axis: new therapeutic opportunities. Annu Rev Pharmacol Toxicol. 2020;60:477–502.

    Article  CAS  PubMed  Google Scholar 

  42. Colica C, Avolio E, Bollero P, Costa de Miranda R, Ferraro S, Sinibaldi Salimei P, De Lorenzo A, Di Renzo L. Evidences of a new psychobiotic formulation on body composition and anxiety. Mediat Inflamm. 2017;2017:5650627.

    Article  Google Scholar 

  43. Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry. 2013;74(10):720–6.

    Article  CAS  PubMed  Google Scholar 

  44. Ansari F, Pourjafar H, Tabrizi A, Homayouni A. The effects of probiotics and prebiotics on mental disorders: a review on depression, anxiety, Alzheimer, and autism spectrum disorders. Curr Pharm Biotechnol. 2020.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Centre Hospitalier de Mouscron, Mouscron, Belgium

    Bárbara Roque Ferreira

  2. Centre for Philosophy of Sciences of the University of Lisbon, Lisbon, Portugal

    Bárbara Roque Ferreira

  3. Department of Psychiatry & Behavioral Sciences and Psychodermatology, Central Michigan University & CMU Medical Education Partners, Saginaw, MI, USA

    Mohammad Jafferany

  4. Wake Forest University, School of Medicine, Winston-Salem, NC, USA

    Arsh Patel

Authors
  1. Bárbara Roque Ferreira
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohammad Jafferany
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arsh Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2020 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Roque Ferreira, B., Jafferany, M., Patel, A. (2020). Common Psychotropic Treatments Used in Dermatology, How and When to Use. In: The Essentials of Psychodermatology. Springer, Cham. https://doi.org/10.1007/978-3-030-45582-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-45582-8_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-45581-1

  • Online ISBN: 978-3-030-45582-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation